These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


74 related items for PubMed ID: 11981732

  • 1. The promise of novel technology for the prevention of intravascular device-related bloodstream infection. II. Long-term devices.
    Crnich CJ, Maki DG.
    Clin Infect Dis; 2002 May 15; 34(10):1362-8. PubMed ID: 11981732
    [Abstract] [Full Text] [Related]

  • 2. The promise of novel technology for the prevention of intravascular device-related bloodstream infection. I. Pathogenesis and short-term devices.
    Crnich CJ, Maki DG.
    Clin Infect Dis; 2002 May 01; 34(9):1232-42. PubMed ID: 11941550
    [Abstract] [Full Text] [Related]

  • 3. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies.
    Maki DG, Kluger DM, Crnich CJ.
    Mayo Clin Proc; 2006 Sep 01; 81(9):1159-71. PubMed ID: 16970212
    [Abstract] [Full Text] [Related]

  • 4. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial.
    Garland JS, Alex CP, Henrickson KJ, McAuliffe TL, Maki DG.
    Pediatrics; 2005 Aug 01; 116(2):e198-205. PubMed ID: 15995005
    [Abstract] [Full Text] [Related]

  • 5. Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: a meta-analysis of prospective, randomized trials.
    Safdar N, Maki DG.
    Clin Infect Dis; 2006 Aug 15; 43(4):474-84. PubMed ID: 16838237
    [Abstract] [Full Text] [Related]

  • 6. ESPEN Guidelines on Parenteral Nutrition: central venous catheters (access, care, diagnosis and therapy of complications).
    Pittiruti M, Hamilton H, Biffi R, MacFie J, Pertkiewicz M, ESPEN.
    Clin Nutr; 2009 Aug 15; 28(4):365-77. PubMed ID: 19464090
    [Abstract] [Full Text] [Related]

  • 7. Nosocomial catheter-related bloodstream infections in a pediatric intensive care unit: risk and rates associated with various intravascular technologies.
    Odetola FO, Moler FW, Dechert RE, VanDerElzen K, Chenoweth C.
    Pediatr Crit Care Med; 2003 Oct 15; 4(4):432-6. PubMed ID: 14525637
    [Abstract] [Full Text] [Related]

  • 8. Risk of catheter-related bloodstream infection with peripherally inserted central venous catheters used in hospitalized patients.
    Safdar N, Maki DG.
    Chest; 2005 Aug 15; 128(2):489-95. PubMed ID: 16100130
    [Abstract] [Full Text] [Related]

  • 9. Antiseptic chamber-containing hub reduces central venous catheter-related infection: a prospective, randomized study.
    León C, Alvarez-Lerma F, Ruiz-Santana S, González V, de la Torre MV, Sierra R, León M, Rodrigo JJ.
    Crit Care Med; 2003 May 15; 31(5):1318-24. PubMed ID: 12771597
    [Abstract] [Full Text] [Related]

  • 10. Do antimicrobial-impregnated central venous catheters prevent catheter-related bloodstream infection?
    McConnell SA, Gubbins PO, Anaissie EJ.
    Clin Infect Dis; 2003 Jul 01; 37(1):65-72. PubMed ID: 12830410
    [Abstract] [Full Text] [Related]

  • 11. Effect of an infection control program using education and performance feedback on rates of intravascular device-associated bloodstream infections in intensive care units in Argentina.
    Rosenthal VD, Guzman S, Pezzotto SM, Crnich CJ.
    Am J Infect Control; 2003 Nov 01; 31(7):405-9. PubMed ID: 14639436
    [Abstract] [Full Text] [Related]

  • 12. Do central venous catheters have advantages over arteriovenous fistulas or grafts?
    Quarello F, Forneris G, Borca M, Pozzato M.
    J Nephrol; 2006 Nov 01; 19(3):265-79. PubMed ID: 16874685
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Urokinase lock or flush solution for prevention of bloodstream infections associated with central venous catheters for chemotherapy: a meta-analysis of prospective randomized trials.
    Kethireddy S, Safdar N.
    J Vasc Access; 2008 Nov 01; 9(1):51-7. PubMed ID: 18379981
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Long-term management of the tunneled venous catheter.
    Liangos O, Gul A, Madias NE, Jaber BL.
    Semin Dial; 2006 Nov 01; 19(2):158-64. PubMed ID: 16551295
    [Abstract] [Full Text] [Related]

  • 17. [Complications of central venous and indwelling catheterization].
    Douard MC, Desruennes E, Kriegel I, Blot F.
    Rev Prat; 2006 Jun 30; 56(12):1281-9. PubMed ID: 16948214
    [Abstract] [Full Text] [Related]

  • 18. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy.
    Fortún J, Grill F, Martín-Dávila P, Blázquez J, Tato M, Sánchez-Corral J, García-San Miguel L, Moreno S.
    J Antimicrob Chemother; 2006 Oct 30; 58(4):816-21. PubMed ID: 16899468
    [Abstract] [Full Text] [Related]

  • 19. Avoiding trouble down the line: the management and prevention of hemodialysis catheter-related infections.
    Lok CE.
    Adv Chronic Kidney Dis; 2006 Jul 30; 13(3):225-44. PubMed ID: 16815229
    [Abstract] [Full Text] [Related]

  • 20. Multilumen central venous catheters increase risk for catheter-related bloodstream infection: prospective surveillance study.
    Templeton A, Schlegel M, Fleisch F, Rettenmund G, Schöbi B, Henz S, Eich G.
    Infection; 2008 Aug 30; 36(4):322-7. PubMed ID: 18663408
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.